Literature DB >> 17127298

Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.

John Nicholas1.   

Abstract

Human herpesvirus 8 (HHV-8) is a gamma-2 herpesvirus, related genetically to simian herpesvirus saimiri (HVS), the prototype virus of this subgroup of the gammaherpesvirus subfamily. HHV-8 DNA is present in all forms of Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), and in most forms of multicentric Castleman's disease (MCD), especially in HIV infected individuals. Of relevance to attempts to explain the molecular basis of HHV-8 associated neoplasia, are the unique genes specified by this virus, in particular angiogenic cytokines viral interleukin-6 (vIL-6) and viral CC-class chemokines (vCCL-1, vCCL-2, vCCL-3), mitogenic signaling membrane proteins variable ITAM-containing protein (VIP) and latency associated membrane protein (LAMP), pro-survival latently-expressed viral interferon regulatory factor (vIRF3), and the kaposin family of proteins that promote cell growth and cytokine production. Also of relevance are the angiogenic and cytokine-inducing viral G protein-coupled receptor (vGPCR), pro-proliferative and pro-survival latency proteins viral FLICE inhibitory protein (vFLIP) and latency-associated nuclear antigen (LANA), and G1-S phase cell-cycle promoter viral cyclin (v-cyclin), proteins specified also by other gamma-2 herpesviruses. The enormous progress on the characterization of the properties and biological activities of these proteins over the last ten years has provided insight into the potential mechanisms of HHV-8-induced neoplasia. Present data suggest that there operates a combination of cell transformation mediated by latently expressed proteins that promote cell proliferation and survival coupled with paracrine signaling functions mediated by either the viral cytokines or viral receptor-induced secreted cellular proteins. This review discusses the properties of the viral proteins believed to contribute to viral neoplasia via these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127298     DOI: 10.2741/2063

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  19 in total

1.  A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.

Authors:  Ramakrishnan Gopalakrishnan; Hittu Matta; Preet M Chaudhary
Journal:  Clin Cancer Res       Date:  2013-07-23       Impact factor: 12.531

Review 2.  Emerging Proviral Roles of Caspases during Lytic Replication of Gammaherpesviruses.

Authors:  Tate Tabtieng; Marta M Gaglia
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 3.  More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Authors:  Marta M Gaglia; Karl Munger
Journal:  Curr Opin Virol       Date:  2018-09-27       Impact factor: 7.090

4.  Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.

Authors:  Emily Cousins; John Nicholas
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

Review 5.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

6.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

7.  Bim nuclear translocation and inactivation by viral interferon regulatory factor.

Authors:  Young Bong Choi; John Nicholas
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

8.  Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation.

Authors:  Charles S Dela Cruz; Srinivas R Viswanathan; Ayman S El-Guindy; Duane Shedd; George Miller
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

9.  Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2.

Authors:  Daming Chen; Yang Gao; John Nicholas
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Heesoon Chang; Lynn M Wachtman; Christine B Pearson; Jong-Soo Lee; Hye-Ra Lee; Steven H Lee; Jeffrey Vieira; Keith G Mansfield; Jae U Jung
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.